The Latest Breaking News on Pharma

Due to innovative drug development and increasing demand for healthcare, the pharma industry is poised to thrive in the foreseeable future. Given the significant prospects of the industry, pharma stocks Novo Nordisk A/S (NVO) and Novartis AG (NVS) look poised for solid growth and might be ideal additions to one’s…

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics (FOLD), Corcept Therapeutics (CORT), and Harmony Biosciences (HRMY) might be solid buys in 2023. Read on.

Given the breakthrough developments and government initiatives, the biotech industry is well-positioned to grow steadily. Therefore, fundamentally strong biotech stocks Amicus Therapeutics (FOLD) and POINT Biopharma (PNT) could be worth buying now. Read on.

The No7 anti-ageing serum is usually £34.95 and has been reduced to £10 as part of Boots' weekly £10 Tuesday offers

Proposal is designed to free up 15m GP appointments over the next two years

Leading healthcare company McKesson’s (MCK) stock looks undervalued at its current price and could be an excellent pick for value investors. Let’s look at some of MCK’s key metrics.

The Police Association says alternative policy could have been pushed through in order to enable roadside drug testing on time.

Government proposals to improve access to primary care are expected on Tuesday.

MedAvail Holdings’ (MDVL) net loss widened by nearly 9% in fiscal 2022. The company has been taking some measures to achieve profitability, but it still looks far away. Amid this backdrop, investors could consider avoiding the stock. Read more….